Business Insider Spain published the article “The pandemic will trigger investment in biotechnology: the most relevant Spanish startups and the sectors with the greatest potential.”
With biotech companies leading the search for a COVID-19 vaccine, improving antibody detection and diagnosis systems, and searching for new treatments, everything indicates that the sector will emerge stronger and get increased interest from investors.
Although the sector has been affected by the pandemic in the short term, forcing the paralysis of ongoing clinical trials, the need for research and technology to offer innovative solutions to health problems has also become evident.
One of the largest operations last year was carried out by the biopharmaceutical company SOM Biotech, which closed a round of financing worth 7 million euros. The company is specialized in identifying new therapeutic activities for drugs already on the market using artificial intelligence.